Journal of Clinical Ligand Assay

Pharmacogenomics Overview: Potential Benefits and Challenges
pp. 67-69(3)
Author: Clarke, William

Analytical Performance of an Automated Immunoassay for Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)
pp. 70-76(7)
Authors: Davis, Gerard J.; Chan, Sabrina S.; Biegalski, Thomas T.; Hemken, Philip M.; Dua, Renu; Elliott, Debra; Dunn, Willard; Sokoll, Lori J.; Chan, Daniel W.; Dowell, Barry L.

Use of Bass Modeling to Define and Analyze the Rate of Adoption for New Clinical Laboratory Markers
pp. 77-80(4)
Authors: Hess, Patrick; Applegate, Mark

Initial Development of Competitive FRET-Aptamer Assays for Monitoring Bone Metabolism
pp. 81-89(9)
Authors: Bruno, John G.; Carrillo, Maria P.; Phillips, Taylor; Crowell, Randy

High-Resolution Isoelectric Separation of Dipeptidyl Peptidase IV Facilitates Molecular Understanding of Posttranslational Modifications, Enzyme Activity, and a Link to Type II Diabetes
pp. 90-97(8)
Authors: O'Mullan, Patrick; Craft, David; Yi, Jizu; Kim, Chae; Gelfand, Craig A.

The Role of Procalcitonin in the Diagnosis of Sepsis and Patient Assignment to Medical Intensive Care
pp. 98-104(7)
Authors: Bernstein, L.H.; Devakonda, A.; Engelman, E.; Pancer, G.; Ferrara, J.; Rucinski, J.; Raoof, S.; George, L.; Melniker, L.

Immunoassays for Drugs of Abuse: Limitations
pp. 105-112(8)
Authors: Kiechle, Frederick L.; Franke, Deanna D.H.